Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06236269
Title HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan (ACROSS-TROP2)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors SOLTI Breast Cancer Research Group
Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
ICO Badalona Badalona Barcelona 08916 Spain Details
ICO Hospitalet L'Hospitalet De Llobregat Barcelona 08907 Spain Details
Hospital Universitari Vall d'Hebrón Barcelona 08035 Spain Details
Hospital Clínic de Barcelona Barcelona 08036 Spain Details
HU Clínico San Cecilio Granada 18016 Spain Details
Fundación Jiménez Díaz Madrid 28040 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Hospital Sant Joan de Reus Reus 43204 Spain Details
Hospital Universitario Virgen del Rocio Sevilla 41013 Spain Details
Hospital Clínico de Valencia Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from for the field